The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

Goodman & Gilman's The Pharmacological Basis of Therapeutics

Brunton, L. L. (1985) · Cited by 7,321 · see citing works

DrugBank: a comprehensive resource for in silico drug discovery and exploration

Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892 · see citing works

How to improve R&D productivity: the pharmaceutical industry's grand challenge

Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · see citing works

How many drug targets are there?

Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · see citing works

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · see citing works

Targeting cancer with small molecule kinase inhibitors

Zhang, J., Yang, P. L., & Gray, N. S. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2559 · Cited by 2,586 · see citing works

A postmodern moral tale: the ethics of research relationships

Somerville, M. (2002) · Nature reviews. Drug discovery · doi:10.1038/nrd773 · Cited by 2,175 · see citing works

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs

Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,832 · see citing works

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798 · see citing works

Structural diversity of G protein-coupled receptors and significance for drug discovery

Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,489 · see citing works

Reorganizing the protein space at the Universal Protein Resource (UniProt)

The UniProt Consortium (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr981 · Cited by 1,223 · see citing works

The protein tyrosine kinase family of the human genome

Robinson, D. R., Wu, Y., & Lin, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203957 · Cited by 1,179 · see citing works

Alzheimer's disease: strategies for disease modification

Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,060 · see citing works

A transposase strategy for creating libraries of circularly permuted proteins

Mehta, M., Liu, S., & Silberg, J. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks060 · Cited by 1,042 · see citing works

Trends in the exploitation of novel drug targets

Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853 · see citing works

TCDB: the Transporter Classification Database for membrane transport protein analyses and information

Saier, M. H. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj001 · Cited by 848 · see citing works

Drugs, their targets and the nature and number of drug targets

Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 833 · see citing works

A Functional-Phylogenetic Classification System for Transmembrane Solute Transporters

Saier, M. H. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.354-411.2000 · Cited by 827 · see citing works

Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin

Almén, M. S., Nordström, K. J. V., Fredriksson, R., & Schiöth, H. B. (2009) · BMC Biology · doi:10.1186/1741-7007-7-50 · Cited by 601 · see citing works

Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes.

Webb, E. C. (1992) · Academic Press eBooks · Cited by 452 · see citing works

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

Thomsen, W. J., Grottick, A. J., Menzaghi, F., Saldana, H. R., Espitia, S. A., Yuskin, D., Whelan, K. T., Martin, M. W., Morgan, M. E., Chen, W., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133348 · Cited by 403 · see citing works

Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib

Domı́nguez, J. M., Fuertes, A., Orozco, L., del Monte-Millán, M., Delgado, E., & Medina, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306472 · Cited by 249 · see citing works

Genomic sciences and the medicine of tomorrow

Drews, J. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1516 · Cited by 246 · see citing works

Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons

Dietrich, M. O., & Horváth, T. L. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3739 · Cited by 202 · see citing works

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

Garcia, J. M., Friend, J., & Allen, S. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1500-1 · Cited by 169 · see citing works

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

Medina, M., Garrido, J. J., & Wandosell, F. G. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00024 · Cited by 124 · see citing works

Keynote review: Is declining innovation in the pharmaceutical industry a myth?

Schmid, E. F., & Smith, D. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03524-5 · Cited by 96 · see citing works

Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732

Kim, Y. M., An, J. J., Jin, Y. J., Rhee, Y., Soo, B., Lee, H. C., & Lim, S.-K. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02165 · Cited by 68 · see citing works

Anti‐CD3 mAbs for treatment of type 1 diabetes

Kaufman, A. C., & Herold, K. C. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.933 · Cited by 59 · see citing works

Outlook for the next 5 years in drug innovation

Berggren, R., Møller, M., Moss, R. A., Poda, P., & Śmietana, K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3744 · Cited by 55 · see citing works

Fumagillin Reduces Adipose Tissue Formation in Murine Models of Nutritionally Induced Obesity

Lijnen, H. R., Frederix, L., & HOEF, B. V. (2010) · Obesity · doi:10.1038/oby.2009.503 · Cited by 48 · see citing works

Recent advances in the pathophysiology and pharmacological treatment of obesity

Chugh, P. K., & Sharma, S. (2012) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2012.01347.x · Cited by 33 · see citing works

Toll-like receptor blocker slows beta cell death in type 1 diabetes

Aldridge, S. (2012) · Nature Biotechnology · doi:10.1038/nbt0212-124c · Cited by 14 · see citing works

Sources of Cancer Research Funding in the United States

McGeary, M., & Burstein, M. C. (1999) · Cited by 6 · see citing works

Trends in GPCR drug discovery: new agents, targets and indications

Hauser, A. S., Attwood, M. M., Rask‐Andersen, M., Schiöth, H. B., & Gloriam, D. E. I. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,609 · see citing works

The evolution of commercial drug delivery technologies

Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361 · see citing works

G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?

Sriram, K., & Insel, P. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111062 · Cited by 1,258 · see citing works

Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation

Zhou, H., & Pang, X. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00305 · Cited by 1,184 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

GPCRdb: an information system for G protein-coupled receptors

Ísberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsøe, K., Hauser, A. S., Vroling, B., Bojarski, A. J., Vriend, G., & Gloriam, D. E. I. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1178 · Cited by 1,067 · see citing works

The druggable genome and support for target identification and validation in drug development

Finan, C., Gaulton, A., Krüger, F. A., Lumbers, R. T., Shah, T., Engmann, J., Galver, L., Kelley, R., Karlsson, A., Santos, R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1166 · Cited by 1,011 · see citing works

FDA-approved small-molecule kinase inhibitors

Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,028 · see citing works

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 845 · see citing works

SLC Transporters as Therapeutic Targets: Emerging Opportunities

Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835 · see citing works

Trends in kinase drug discovery: targets, indications and inhibitor design

Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 807 · see citing works

PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755 · see citing works

Pharmacogenomics of GPCR Drug Targets

Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A., Gloriam, D. E. I., & Babu, M. M. (2017) · Cell · doi:10.1016/j.cell.2017.11.033 · Cited by 611 · see citing works

Allosteric sodium in class A GPCR signaling

Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.002 · Cited by 516 · see citing works

International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein–Coupled Receptors

Hamann, J., Aust, G., Araç, D., Engel, F. B., Formstone, C. J., Fredriksson, R., Hall, R. A., Harty, B. L., Kirchhoff, C., Knapp, B., et al. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009647 · Cited by 489 · see citing works

Emerging Diversity in Lipid–Protein Interactions

Corradi, V., Sejdiu, B. I., Galloso, H. M., Abdizadeh, H., Noskov, S. Y., Marrink, ‪. J., & Tieleman, D. P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00451 · Cited by 458 · see citing works

Recent developments of HDAC inhibitors: Emerging indications and novel molecules

Bondarev, A. D., Attwood, M. M., Jonsson, J., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14889 · Cited by 440 · see citing works

The Concise Guide to PHARMACOLOGY 2013/14: Enzymes

Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 423 · see citing works

DGIdb 2.0: mining clinically relevant drug–gene interactions

Wagner, A. H., Coffman, A. C., Ainscough, B. J., Spies, N. C., Skidmore, Z. L., Campbell, K. M., Krysiak, K., Pan, D., McMichael, J. F., Eldred, J. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1165 · Cited by 413 · see citing works

Drug Affinity Responsive Target Stability (DARTS) for Small-Molecule Target Identification

Pai, M. Y., Lomenick, B., Hwang, H., Schiestl, R. H., McBride, W. H., Loo, J. A., & Huang, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2269-7_22 · Cited by 362 · see citing works

How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets

Doak, B. C., Zheng, J., Dobritzsch, D., & Kihlberg, J. O. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01286 · Cited by 345 · see citing works

Drugging Membrane Protein Interactions

Yin, H. H., & Flynn, A. D. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-092115-025322 · Cited by 342 · see citing works

Cell permeability beyond the rule of 5

Matsson, P., Doak, B. C., Over, B., & Kihlberg, J. O. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.013 · Cited by 300 · see citing works

In silico design of novel probes for the atypical opioid receptor MRGPRX2

Lansu, K., Karpiak, J., Liu, J., Huang, X.-P., McCorvy, J. D., Kroeze, W. K., Che, T., Nagase, H., Carroll, F. I., Jin, J., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2334 · Cited by 293 · see citing works

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales

Dahlén, A. D., Dashi, G., Maslov, I. O., Attwood, M. M., Jonsson, J., Trukhan, V., & Schiöth, H. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.807548 · Cited by 280 · see citing works

Nanobodies to Study G Protein–Coupled Receptor Structure and Function

Manglik, A., Kobilka, B. K., & Steyaert, J. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104710 · Cited by 257 · see citing works

Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors

Vijayan, R., He, P., Modi, V., Duong‐Ly, K. C., Ma, H., Peterson, J. R., Dunbrack, R. L., & Levy, R. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501603h · Cited by 255 · see citing works

The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore

Dormán, G., Nakamura, H., Pulsipher, A., & Prestwich, G. D. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00342 · Cited by 249 · see citing works

Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5

Sebastiano, M. R., Doak, B. C., Backlund, M., Poongavanam, V., Over, B., Ermondi, G., Caron, G., Matsson, P., & Kihlberg, J. O. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00347 · Cited by 238 · see citing works

Drugging Undruggable Molecular Cancer Targets

Lazo, J. S., & Sharlow, E. R. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103440 · Cited by 225 · see citing works

ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors

Roskoski, R. J. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.001 · Cited by 217 · see citing works

GPCRdb: the G protein‐coupled receptor database – an introduction

Munk, C., Ísberg, V., Mordalski, S., Harpsøe, K., Rataj, K., Hauser, A. S., Kolb, P., Bojarski, A. J., Vriend, G., & Gloriam, D. E. I. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13509 · Cited by 212 · see citing works

Systematic functional profiling of transcription factor networks in Cryptococcus neoformans

Jung, K., Yang, D., Maeng, S., ‍Lee, K.-T., So, Y.-S., Hong, J., Choi, J., Byun, H.-J., Kim, H., Bang, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7757 · Cited by 200 · see citing works

Advances in kinase targeting: current clinical use and clinical trials

Rask‐Andersen, M., Zhang, J., Fabbro, D., & Schiöth, H. B. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.007 · Cited by 181 · see citing works

Mechanisms of adhesion G protein–coupled receptor activation

Vizurraga, A., Adhikari, R., Yeung, J., Yu, M., & Tall, G. G. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.007423 · Cited by 179 · see citing works

Systematic functional analysis of kinases in the fungal pathogen Cryptococcus neoformans

‍Lee, K.-T., So, Y.-S., Yang, D., Jung, K.-W., Choi, J., Lee, D., Kwon, H., Jang, J., Wang, L. L., Cha, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12766 · Cited by 166 · see citing works

Design and Challenges of Radiopharmaceuticals

Vermeulen, K., Vandamme, M., Bormans, G. M., & Cleeren, F. (2019) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2019.07.001 · Cited by 152 · see citing works

An update on extra-oral bitter taste receptors

Tuzim, K., & Korolczuk, A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03067-y · Cited by 144 · see citing works

Peptide-based protease inhibitors from plants

Hellinger, R., & Gruber, C. W. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.026 · Cited by 140 · see citing works

18F-Labeled Peptides: The Future Is Bright

Richter, S., & Wuest, F. R. (2014) · Molecules · doi:10.3390/molecules191220536 · Cited by 136 · see citing works

G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits

Azam, S., Haque, M. E., Jakaria, M., Jo, S.-H., Kim, I., & Choi, D. (2020) · Cells · doi:10.3390/cells9020506 · Cited by 124 · see citing works

muTarget : A platform linking gene expression changes and mutation status in solid tumors

Nagy, Á. M., & Győrffy, B. (2020) · International Journal of Cancer · doi:10.1002/ijc.33283 · Cited by 124 · see citing works

Host-Directed Therapies for Tuberculosis: Figure 1.Preprint

Tobin, D. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021196 · Cited by 119 · see citing works

Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning

Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M. M., Griffiths, E., Bellows, D. S., Wright, G. D., & Tyers, M. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.003 · Cited by 122 · see citing works

Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics

Barman, P., Joshi, S., Sharma, S., Preet, S., Sharma, S., & Saini, A. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10524-3 · Cited by 122 · see citing works

SZDB: A Database for Schizophrenia Genetic Research

Wu, Y., Yao, Y., & Luo, X. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw102 · Cited by 113 · see citing works

pathDIP: an annotated resource for known and predicted human gene-pathway associations and pathway enrichment analysis

Rahmati, S., Abovsky, M., Pastrello, C., & Jurišica, I. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1082 · Cited by 118 · see citing works

The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR–Ligand Interactions

Heifetz, A., Chudyk, E. I., Gleave, L., Aldeghi, M., Cherezov, V., Fedorov, D. G., Biggin, P. C., & Bodkin, M. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00644 · Cited by 116 · see citing works

Soluble ligands as drug targets

Attwood, M. M., Jonsson, J., Rask‐Andersen, M., & Schiöth, H. B. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0078-4 · Cited by 110 · see citing works

Gi/o-Protein Coupled Receptors in the Aging Brain

de Oliveira, P. G., Ramos, M. L., Amaro, A. J. M., Dias, R. A., & Vieira, S. I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00089 · Cited by 106 · see citing works

Disciplined approach to drug discovery and early development

Plenge, R. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2608 · Cited by 100 · see citing works

The impact of in silico screening in the discovery of novel and safer drug candidates

Rognan, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.034 · Cited by 99 · see citing works

Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space

Poongavanam, V., Doak, B. C., & Kihlberg, J. O. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.05.010 · Cited by 98 · see citing works

HDX-MS guided drug discovery: small molecules and biopharmaceuticals

Marciano, D. P., Dharmarajan, V., & Griffin, P. R. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.08.007 · Cited by 97 · see citing works

The landscape of natural product diversity and their pharmacological relevance from a focus on the Dictionary of Natural Products®

Chassagne, F., Cabanac, G., Hubert, G., David, B., & Marti, G. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-019-09606-2 · Cited by 96 · see citing works

Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights

Zheng, P., Li, J., & Kros, J. M. (2017) · Medicinal Research Reviews · doi:10.1002/med.21463 · Cited by 97 · see citing works

Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?

Poongavanam, V., Danelius, E., Peintner, S., Alcaraz, L., Caron, G., Cummings, M. D., Wlodek, S. T., Erdélyi, M., Hawkins, P. C. D., Ermondi, G., et al. (2018) · ACS Omega · doi:10.1021/acsomega.8b01379 · Cited by 92 · see citing works

Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic

Lencz, T., & Malhotra, A. K. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.28 · Cited by 91 · see citing works

Intracellular Transfer of Na+ in an Active-State G-Protein-Coupled Receptor

Vickery, O. N., Carvalheda, C. A., Zaidi, S. A., Pisliakov, A. V., Katritch, V., & Zachariae, U. (2017) · Structure · doi:10.1016/j.str.2017.11.013 · Cited by 86 · see citing works

Synaptic changes induced by melanocortin signalling

Caruso, V., Lagerström, M. C., Olszewski, P. K., Fredriksson, R., & Schiöth, H. B. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3657 · Cited by 89 · see citing works

The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor

Miller, R. L., Thompson, A. A., Trapella, C., Guerrini, R., Malfacini, D., Patel, N., Han, G. W., Cherezov, V., Calò, G., Katritch, V., et al. (2015) · Structure · doi:10.1016/j.str.2015.07.024 · Cited by 81 · see citing works

Understanding Membrane Protein Drug Targets in Computational Perspective

Gong, J., Chen, Y., Pu, F., Sun, P., He, F., Zhang, L., Li, Y., Ma, Z., & Wang, H. (2018) · Current Drug Targets · doi:10.2174/1389450120666181204164721 · Cited by 79 · see citing works

Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters

Diallinas, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00207 · Cited by 75 · see citing works

In vitro expression and analysis of the 826 human G protein-coupled receptors

Lv, X., Liu, J., Shi, Q., Tan, Q., Wu, D., Skinner, J. J., Walker, A. L., Zhao, L., Gu, X.-X., Chen, N., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0263-8 · Cited by 72 · see citing works

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

Bondarev, A. D., Attwood, M. M., Jonsson, J., Chubarev, V. N., Tarasov, V. V., Liu, W., & Schiöth, H. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1057083 · Cited by 73 · see citing works

Computational design of thermostabilizing point mutations for G protein-coupled receptors

Popov, P. A., Peng, Y., Shen, L., Stevens, R. C., Cherezov, V., Liu, Z., & Katritch, V. (2018) · eLife · doi:10.7554/elife.34729 · Cited by 71 · see citing works

Trends in Drug Delivery Systems for Natural Bioactive Molecules to Treat Health Disorders: The Importance of Nano-Liposomes

Cardoso, R. V., Pereira, P. R., Freitas, C. S., & Paschoalin, V. M. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122808 · Cited by 69 · see citing works

G Protein–Coupled Receptor (GPCR) Expression in Native Cells: “Novel” endoGPCRs as Physiologic Regulators and Therapeutic Targets

Insel, P. A., Wilderman, A. S., Zambon, A. C., Snead, A. N., Murray, F., Aroonsakool, N., McDonald, D., Zhou, S. M., McCann, T., Zhang, L., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098129 · Cited by 66 · see citing works

HTS-compatible FRET-based conformational sensors clarify membrane receptor activation

Scholler, P., Moreno‐Delgado, D., Lecat‐Guillet, N., Doumazane, E., Monnier, C., Charrier‐Savournin, F., Fabre, L., Chouvet, C., Soldevila, S., Lamarque, L., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2286 · Cited by 66 · see citing works

Orphan Drugs and Their Impact on Pharmaceutical Development

Attwood, M. M., Rask‐Andersen, M., & Schiöth, H. B. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.03.003 · Cited by 66 · see citing works

Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc

Sato, S., Huang, X., Kroeze, W. K., & Roth, B. L. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.106112 · Cited by 61 · see citing works

Histone deacetylases and their inhibitors in inflammatory diseases

Zhang, S.-Y., Zhang, L., Wen, R., Yang, N., & Zhang, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117295 · Cited by 62 · see citing works

Integrating structural and mutagenesis data to elucidate GPCR ligand binding

Munk, C., Harpsøe, K., Hauser, A. S., Ísberg, V., & Gloriam, D. E. I. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.003 · Cited by 55 · see citing works

DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity

Schröder, M., Bullock, A. N., Fedorov, O., Bracher, F., Chaikuad, A., & Knapp, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00898 · Cited by 55 · see citing works

Recent advances in screening of enzymes inhibitors based on capillary electrophoresis

Cheng, M., & Chen, Z. (2018) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.05.002 · Cited by 53 · see citing works

Molecular assembly of rhodopsin with G protein-coupled receptor kinases

He, Y., Gao, X., Goswami, D., Hou, L., Pal, K., Yin, Y., Zhao, G., Ernst, O. P., Griffin, P. R., Melcher, K., et al. (2017) · Cell Research · doi:10.1038/cr.2017.72 · Cited by 52 · see citing works

Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring

Kopra, K., Vuorinen, E., Blanco, M. A., Wang, Q., Eskonen, V., Gillette, W., Pulliainen, A. T., Holderfield, M. T., & Härmä, H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05126 · Cited by 52 · see citing works

Advances in Capillary Electrophoresis-Based Enzyme Assays

Scriba, G. K. E., & Belal, F. F. (2015) · Chromatographia · doi:10.1007/s10337-015-2912-0 · Cited by 52 · see citing works

Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine

Wu, X., Xing, X., Dowlut, D., Zeng, Y., Liu, J., & Liu, X. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.03.033 · Cited by 49 · see citing works

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Hampel, H. J., Vergallo, A., Caraci, F., Cuello, A. C., Lemercier, P., Vellas, B. J., Giudici, K. V., Baldacci, F., Hänisch, B., Haberkamp, M., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108081 · Cited by 50 · see citing works

CHARACTERISTICS OF DRUG COMBINATION THERAPY IN ONCOLOGY BY ANALYZING CLINICAL TRIAL DATA ON CLINICALTRIALS.GOV

Wu, M., Sirota, M., Butte, A., & Chen, B. (2014) · Pacific Symposium on Biocomputing · doi:10.1142/9789814644730_0008 · Cited by 55 · see citing works

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

Andradas, C., Blasco-Benito, S., Castillo‐Lluva, S., Dillenburg-Pilla, P., Dı́ez-Alarcia, R., Juanes-García, A., García-Taboada, E., Hernando-Llorente, R., Soriano, J., Hamann, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10206 · Cited by 50 · see citing works

Assays with Detection of Fluorescence Anisotropy: Challenges and Possibilities for Characterizing Ligand Binding to GPCRs

Rinken, A., Lavõgina, D., & Kopanchuk, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.004 · Cited by 49 · see citing works

Survey of Similarity-Based Prediction of Drug-Protein Interactions

Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 49 · see citing works

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology

Hampel, H. J., Goetzl, E. J., Kapogiannis, D., Lista, S., & Vergallo, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00310 · Cited by 47 · see citing works

Structure and Cooperativity in Substrate–Enzyme Interactions: Perspectives on Enzyme Engineering and Inhibitor Design

Rajakumara, E., Abhishek, S., Nitin, K., Saniya, D., Bajaj, P., Schwaneberg, U., & Davari, M. D. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00500 · Cited by 49 · see citing works

Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1

Smith, N. J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00275 · Cited by 47 · see citing works

PDID: database of molecular-level putative protein–drug interactions in the structural human proteome

Wang, C., Hu, G., Wang, K., Bryliński, M., Xie, L., & Kurgan, L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv597 · Cited by 47 · see citing works

Bypass of Candida albicans Filamentation/Biofilm Regulators through Diminished Expression of Protein Kinase Cak1

Woolford, C. A., Lagree, K., Xu, W., Aleynikov, T., Adhikari, H., Sánchez, H., Cullen, P. J., Lanni, F., Andes, D. R., & Mitchell, A. P. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006487 · Cited by 46 · see citing works

Structural and Functional View of Polypharmacology

Moya‐García, A. A., Adeyelu, T. T., Krüger, F. A., Dawson, N. L., Lees, J., Overington, J. P., Orengo, C. A., & Ranea, J. A. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10012-x · Cited by 44 · see citing works

Systematic illumination of druggable genes in cancer genomes

Jiang, J., Yuan, J., Hu, Z., Zhang, Y., Zhang, T., Xu, M., Long, M., Fan, Y., Tanyi, J. L., Montone, K. T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110400 · Cited by 46 · see citing works

Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells

Seo, Y., Kim, Y. S., Lee, K. E., Park, T. H., & Kim, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176851 · Cited by 45 · see citing works

Recent Advances in Effect‐directed Enzyme Assays based on Thin‐layer Chromatography

Bräm, S., & Wolfram, E. (2017) · Phytochemical Analysis · doi:10.1002/pca.2669 · Cited by 43 · see citing works

Immobilized‐enzyme reactors integrated with capillary electrophoresis for pharmaceutical research

Schejbal, J., & Glatz, Z. (2017) · Journal of Separation Science · doi:10.1002/jssc.201700905 · Cited by 43 · see citing works

Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia

Alsultan, A., Alghamdi, W. A., Alghamdi, J., Alharbi, A., Aljutayli, A., Albassam, A. A., Almazroo, O. A., & Alqahtani, S. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.08.012 · Cited by 40 · see citing works

Dynamic protein interfaces and conformational landscapes of membrane protein complexes

Kharche, S., & Sengupta, D. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.001 · Cited by 37 · see citing works

New Approaches to Difficult Drug Targets: The Phosphatase Story

Lazo, J. S., McQueeney, K. E., & Sharlow, E. R. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217721142 · Cited by 36 · see citing works

VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization

Bolgár, B., & Antal, P. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1845-z · Cited by 36 · see citing works

A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL

Mutowo, P., Bento, A. P., Dedman, N., Gaulton, A., Hersey, A., Lomax, J., & Overington, J. P. (2016) · Journal of Biomedical Semantics · doi:10.1186/s13326-016-0102-0 · Cited by 36 · see citing works

NMR analysis of GPCR conformational landscapes and dynamics

Casiraghi, M., Point, É., Pozza, A., Moncoq, K., Banères, J., & Catoire, L. J. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.019 · Cited by 36 · see citing works

Trends in the exploitation of novel drug targets

Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853 · see citing works

Trends in Exploration of Therapeutic Targets

Zheng, C. J., Han, L., Yap, C. W., Xie, B., & Chen, Y. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.2.886480 · Cited by 14 · see citing works

The Therapeutic Target Database: an Internet resource for the primary targets of approved, clinical trial and experimental drugs

Liu, X., Zhu, F., Ma, X., Tao, L., Zhang, J., Yang, S., Wei, Y., & Chen, Y. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.586635 · Cited by 24 · see citing works

The evolving landscape of drug targets

Halip, L., Avram, S. I., Overington, J. P., Al‐Lazikani, B., Curpan, R. F., Sirimulla, S., Pushechnikov, A. O., Beccari, A. R., Savchuk, N., & Oprea, T. I. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01530-3

Construction of Enriched Resource for Primary Therapeutic Targets of Approved and Clinical Trial Drugs

Yang, H. J., Yu, C., Li, Y., & Zhu, F. (2017) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2017.53001